Aims A domain peptide (DP) matching the Gly 2460 -Pro 2495 region of the cardiac type-2 ryanodine receptor (RyR2), DPc10, is known to mimic channel dysfunction associated with catecholaminergic polymorphic ventricular tachycardia (CPVT), owing to its interference in a normal interaction of the N-terminal (1-600) and central (2000-2500) domains (viz. domain unzipping). Using DPc10 and two other DPs harboring different mutation sites, we investigated the underlying mechanism of abnormal Ca 2þ cycling in failing hearts. Methods and results Sarcoplasmic reticulum (SR) vesicles and cardiomyocytes were isolated from dog left ventricular muscles for Ca 2þ leak and spark assays. The RyR2 moiety of the SR was fluorescently labelled with methylcoumarin acetate (MCA) using DPs corresponding to the 163-195 and 4090-4123 regions of RyR2 (DP163-195 and DP4090-4123, respectively) as site-directed carriers. Both DPs mediated a specific MCA fluorescence labelling of RyR2. Addition of either DP to the MCA-labelled SR induced domain unzipping, as evidenced by an increased accessibility of the bound MCA to a largesize fluorescence quencher. Both SR Ca 2þ leak and Ca 2þ spark frequency (SpF) were markedly increased in failing cardiomyocytes. Upon introduction of DP163-195 or DP4090-4123 into normal SR or cardiomyocytes, both Ca 2þ leak and SpF increased to the levels comparable with those of failing myocytes. K201 (JTV519) suppressed all of the effects induced by DP163-195 (domain unzipping and increased Ca 2þ leak and SpF) or those in failing cardiomyocytes, but did not suppress the effects induced by DP4090-4123. Conclusion Defective inter-domain interaction between N-terminal and central domains induces diastolic Ca 2þ leak, leading to heart failure and lethal arrhythmia. Mutation at the C-terminal region seen in CPVT does not seem to communicate with the aforementioned N-terminal and central interdomain interaction, although spontaneous Ca 2þ leak is similarly induced.
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Introduction
A Ca 2þ release channel protein, the ryanodine receptor (RyR2) in sarcoplasmic reticulum (SR), plays a key role in a transient increase of the intracellular Ca 2þ concentration from nmol/L to mmol/L during cardiac muscle contraction. 1 A considerable amount of evidence has been accumulated that diastolic Ca 2þ leak through the RyR2 is one of the problems in failing hearts. 1 The Ca 2þ leak reduces SR Ca 2þ load, thereby decreasing the SR Ca 2þ required for an efficient contraction, causing contractile dysfunction. Moreover, the diastolic Ca 2þ leak triggers delayed afterdepolarization (DAD) caused by the entry of Na þ via Na þ -Ca 2þ exchanger, which occasionally results in lethal arrhythmia. 2 It has been suggested that dissociation of RyR2-bound FKBP12.6 due to PKA-mediated hyperphosphorylation may be the cause of diastolic Ca 2þ leak seen in various types of heart failure. 3 However, several reports suggest that PKA hyper-phosphorylation and subsequent FKBP12.6 dissociation may not necessarily be the primary cause of Ca 2þ leak and heart failure. 4, 5 In our recent report we have shown that defective interactions between the N-terminal domain (1-600) and central domain (2000-2500) of RyR2, harboring many mutation sites of catecholaminergic polymorphic ventricular tachycardia (CPVT) 6, 7 or ARVC, 8 cause Ca 2þ leak in failing hearts and reduced SR Ca 2þ load, leading to contractile dysfunction. 9 The causative mechanism of such dysfunctions seems to be as follows. In normal hearts these domains are interacting with each other forming a zipped state, which stabilizes the closed state of the Ca 2þ channel. However, in failing SR the interaction becomes loose (domain unzipping), which de-stabilizes the closed state making the channel leaky. Reversal of the unzipped state to a normal zipped state by K201 (JTV519) restores normal channel gating in otherwise leaky channels of failing SR. 9 Almost 40% of the reported CPVT mutation sites are within C-terminal region of RyR2. Recently, Liu et al. 10 reported that in the knock-in mouse model of human CPVT mutant of RyR2 (R4496C), sustained bi-directional ventricular tachycardia occurred, and that K201 was without effect on such lethal arrhythmia. These findings suggest that the mutation at C-terminal region may induce Ca 2þ sparks or DAD, leading to the lethal arrhythmia, but the defectiveness of RyR2 due to the mutation within C-terminal domain may not be ascribable to the aforementioned defective inter-domain interaction between the N-terminal and central regions. George et al. 11 made an attempt to reconstitute the channel gating function by co-expressing a truncated cytoplasmic N-terminal segment (segment P) and C-terminal segment containing channel domain (segment C) of RyR2, and found that in order to confer the agonist-regulated gating function to the channel domain, both Segments P and C must contain a common overlapping segment designated as I-domain that corresponds to residues 3722-4610. This suggests that the I-domain transduces cytoplasmic events to the Ca 2þ pore-forming domain. Taken together, inter-domain interaction among N-terminal, central, I-domain, and transmembrane channel domain appears to play a pivotal regulatory role in Ca 2þ channel function, although the precise mode of conformational alterations arising from mutations in distinct RyR2 domains may be different.
In the present domain peptide (DP) probe study, we investigated the mode of inter-domain interactions among the three mutable domains (i.e. N-terminal, central, and I-domains) and their involvement in channel regulation. Here, we show that defective inter-domain interactions among these mutable domains indeed cause abnormal Ca 2þ cycling in failing hearts.
Methods

Materials
FK506 and K201 were provided by Fujisawa Pharmaceutical Co. Ltd (Osaka, Japan) and Aetas Co. Ltd (Tokyo Japan), respectively.
Animal model
In beagle dogs weighing 10-13 kg, we induced heart failure by continuous application of rapid ventricular (RV) pacing at 250 b.p.m. using an externally programmed miniature pacemaker (Medtronic Inc., Minneapolis) for 28 days, as described elsewhere. 12 This study conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85-23, revised 1996) . The care of the animals and the protocols used were in accord with guidelines laid down by the Animal Ethics Committee of Yamaguchi University School of Medicine.
Preparation of sarcoplasmic reticulum vesicles
We prepared SR vesicles from dog LV muscle as described elsewhere. 12 Left ventricles were homogenized in a solution containing 30 mM Tris-malate, 0.3 M sucrose, 5 mg/L leupeptin, and 0.1 mmol/L PMSF,pH 7.0 (solution I). The homogenate was centrifuged at 5500g for 10 min and the resultant supernatant was filtered through four layers of cheesecloth before centrifugation at 12 000g for 20 min. The supernatant was again filtered through cheesecloth and centrifuged at 143 000g for 30 min. The pellet was resuspended in a solution containing 0. Peptides were synthesized on an Applied Biosystems model 431A synthesizer employing Fmoc (N-(9-fluorenyl)methoxycarbonyl) as the alpha-amino protecting group, as described previously.
14 The peptides were cleaved and de-protected with 95% trifluoroacetic acid and purified by reversed-phase high-pressure liquid chromatography.
Ca
21
-uptake and Ca uptake was initiated by the addition of 0.5 mmol/L ATP into the reaction solution, and the time course of Ca 2þ uptake was monitored spectrophotometrically with fluo 3 as a Ca 2þ indicator (excitation at 480 nm, emission at 530 nm). After the Ca 2þ uptake had reached a plateau, DP was added in the presence of 0.5 mmol/L thapsigargin to inhibit SR Ca 2þ -ATPase activity, and the resultant Ca 2þ leak was measured. The Ca 2þ leak was expressed as the ratio of the amount of Ca 2þ leaked out from the SR at 60 s after the addition of thapsigargin to the amount of total Ca 2þ uptake.
-leak assays
Inter-domain interaction within RyR2
Site-directed fluorescent labelling of the RyR
Specific fluorescent labelling of RyR2 in SR vesicles was performed using the cleavable hetero-bifunctional cross-linking reagent sulfosuccinimidyl 3-((2-(7-azido-4-methylcoumarin-3-acetamido) ethyl) dithio)propionate (SAED) from PIERCE (IL), with various DPs (DPc10, DP163-195, or DP4090-4123), as site-specific carriers. This method for the site-directed fluorescent labelling of the RyR2 was basically the same as the method used for the DP4-mediated MCA (methylcoumarin acetate)-labelling of RyR1. 15 Briefly, peptide-SAED conjugate was formed by incubating 0.5 mmol/L peptide with 0.5 mmol/L SAED in a 20 mmol/L HEPES (pH 7.5) solution for 60 min at 228C in the dark. The reaction was quenched by 20 mmol/L lysine. Unreacted SAED was removed using ion exchange column (GE HiTrap Q XL). The peptide-SAED conjugate (5 mmol/L in a final concentration) was mixed with 2 mg/mL SR protein in the sample solution containing a 1 mmol/L EGTA/calcium buffer (1.0 mmol/L free Ca 2þ ) in the dark and photolyzed with UV light in a Pyrex tube at 48C for 2 min. Beta-mercaptoethanol was added (100 mmol/L in a final concentration) to cleave the disulfide bond of SAED. After incubation on ice for 1 h, the mixture was centrifuged at 100 000g for 15 min, and the sedimented vesicles were resuspended in the sample solution to a final protein concentration of 10 mg/mL.
Fluorescence quenching assay of the MCA probe attached to the binding sites of DPc10, DP163-195, or DP4090-4123
The zipping/unzipping mode of regulatory domains within RyR2 was evaluated as described previously. 9, 16 To make the large-size quencher, QSY w 7 carboxylic acid (Mr ¼ 791.32) was conjugated with BSA by incubating 5 mmol/L QSY w 7 carboxylic acid with 0.5 mmol/L bovine serum albumin (BSA) in 20 mmol/L HEPES (pH 7.5) for 60 min at 228C in the dark. Unreacted QSY 7 carboxylic acid was removed by means of Sephadex G50 gel filtration. Fluorescence quenching by both QSY w 7 carboxylic acid-BSA conjugate (a macromolecular quencher) and unconjugated QSY w (a small-size quencher) was performed by measuring steady-state fluorescence of the labelled MCA (excitation at 368 nm, emission at 455 nm) in the presence or absence of various peptides and/or compounds. The data were analysed using the Stern-Volmer equation:
where F and Fo are fluorescence intensities in the presence and in the absence of added quencher; K Q , quenching constant, which is the measure of the accessibility of the proteinbound probe to the quencher; [Q], the concentration of QSY w 7 carboxylic acid-BSA conjugate.
The principle of the fluorescence quench assay of domain unzipping is that a large-size quencher QSY w 7 carboxylic acid-BSA conjugate is not accessible to the attached MCA in the zipped state, whereas it becomes accessible to the MCA in the unzipped state.
Immunoblot analysis
We performed immunoblot analyses of RyR2-bound FKBP12.6 as described previously. 12 Co-immunoprecipitation of FKBP12.6 with RyR2 from the solubilized SR was performed using anti-RyR antibody (Oncogene Research Products), followed by immunoblotting with anti-FKBP12 (C-19) antibody (Santa Cruz Biotechnology).
Preparation of isolated cardiomyocytes
Cardiomyocytes were isolated from the LV free wall as described previously. 9, 17 In brief, a wedge of LV free wall, perfused by a branch of the left circumflex coronary artery, was dissected free from the heart and perfused with collagenase-containing buffer. LV myocardium was minced with scissors in fresh collagenasecontaining buffer. Then, rod-shaped adult canine cardiomyocytes were prepared by retrograde perfusion of quickly excised hearts with 95%O 2 /5%CO 2 -bubbled Minimal Essential Medium (Sigma) supplemented with 50 mmol/L Ca 2þ , 0.5 mg/mL collagenase B, 0.5 mg/mL collagenase D, and 0.02 mg/mL protease type XIV. The concentration of Ca 2þ was then gradually increased to a final concentration of 1 mmol/L by changing the incubation medium (50 mmol/L, 125 mmol/L, 300 mmol/L, and then 1 mmol/L). The isolated canine cardiomyocytes were transferred to laminin-coated glass culture dishes, and incubated for 12 h at 378C in 5%CO 2 / 95%O 2 atmosphere.
Incorporation of domain peptides into cardiomyocytes
The DP was incorporated into the cells using a protein delivery reagent (Bioporter, Gene Therapy Systems, Inc., CA), as described previously. 9 Successful incorporation of the DP into the cell was confirmed by detecting the fluorescence signal of the peptide prelabelled with Alexa Fluor 488 (Molecular Probes, OR). 19 The analysis involved general image parameters (number of detected sparks, spark frequency) as well as individual spark parameters (Amplitude; FWHM, full width at half maximum; FDHM, full duration at half maximum).
Analysis of
Statistics
Paired or unpaired t-test was used for statistical comparison of the data corresponding to the normal and defective inter-domain interactions. We also used ANOVA with a post hoc Scheffe's test for statistical comparison of concentration-dependent data. Data are expressed as means+SD. We accepted a P-value less than 0.05 as statistically significant. Addition of 0.5 mmol/L thapsigargin to normal SR vesicles at the steady-state of ATP-dependent Ca 2þ uptake produced little Ca 2þ leak, while addition of 3-100 mmol/L DP163-195, or DP4090-4123, together with 0.5 mmol/L thapsigargin produced a pronounced leak ( Figure 1A) . However, neither DP163-195-mut nor DP4090-4123-mut induced Ca 2þ leak (data not shown). Figure 1B shows the effect of DP2460-2495 (DPc10), DP163-195, or DP4090-4123 on dissociation of FKBP12.6 from RyR2 in normal SR. None of these peptides dissociated FKBP12.6 from RyR2. The Ca 2þ leak induced by DP163-195 was almost completely inhibited by 0.3 mmol/L K201, whereas the Ca 2þ leak induced by DP4090-4123 was not inhibited by K201 ( Figure 1C) . In failing SR, spontaneous Ca 2þ leak took place without addition of the peptides (DP163-195 and DP4090-4123), and the addition of these peptides produced little or no further increase in Ca 2þ leak. The Ca 2þ leak was inhibited by K201, although K201 was without effect in the presence of DP4090-4123 ( Figure 1D ). Figure 2 shows the fluorescence gel pictures of the MCAlabelled RyR2. Each of these peptides used as a site direction carrier (DPc10, DP163-195, or DP4090-4123) mediated a specific MCA fluorescence labelling of RyR2. However, each of the human ARVC or CPVT mutants of these peptides {Arg-2474-Ser mutation (DPc10mut), Arg-176-Gln mutation (DP163-195-mut), or Asn-4104-Lys mutation (DP4090-4123-mut)} did not mediate fluorescence labelling (Figure 2, left) . An excess concentration of each unlabelled peptide (10 mmol/L) also prevented DP(DP163-195 or DP4090-4123)-mediated MCA labelling ( Figure 2, right) . In our previous report, 9 an excess concentration of unlabelled DPc10 also prevented the DPc10-mediated MCA labelling.
Specific fluorescent labelling of the peptide binding domains of RyR2
Spectroscopic monitoring of the changes in the mode of inter-domain interactions induced by domain peptide (DP163-195 or DP4090-4123)
In order to monitor the mode of the inter-domain interactions, we adopted the fluorescence quenching technique. 16 The MCA probe that has been attached to the critical domain is expected to be inaccessible to a bulky fluorescence quencher (QSY-BSA conjugate) in a zipped configuration (because in this case the probe is occluded between the interacting domains), while it will become accessible to the quencher upon unzipping (see Methods). The accessibility of the protein-bound MCA to the QSY-BSA quencher, i.e. the extent of domain unzipping, can be quantitatively determined as the slope (¼the quenching constant, K Q ) of the Stern-Volmer plot (
The data of fluorescence quenching assay are shown in Figure 3 . When MCA labelling was mediated by DP163-195 ( Figure 3A) , DP163-195 increased the slope (K Q ) in a concentration-dependent manner, indicating that this peptide interfered with the inter-domain interaction between the N-terminal and central domains, causing domain unzipping ( Figure 5, a) . In this MCA-labelled RyR2 using DP163-165 as a carrier, DP4090-4123 had no effect on the K Q , indicating that DP4090-4123 has no effect on the interdomain interaction between N-terminal and central domains ( Figure 5, b) . K201 inhibited the increase in K Q induced by DP163-195 (cf: Scheme 1-f), but DP163-195mut had no effect. The data with the RyR2, MCA-labelled with DP4090-4123, are shown in Figure 3B . DP4090-4123 increased K Q , indicating that the peptide produced domain unzipping between I-domain and the putative partner domain of I-domain (IP domain) ( Figure 5, b) . DP4090-4123-mut had no effect. Interestingly in this case when MCA was introduced via Figure 3A) or DP4090-4123 ( Figure 3B ) as well. The K Q in the RyR2 of failing SR was significantly larger compared with the K Q in the normal RyR2 without added peptide ( Figure 5, d) , but was comparable with the value of normal RyR2 that was reached after the addition of DP (4090-4123 or 163-195) ( Figure 5, a or b) . Addition of these DP to the failing RyR2 produced no further increase in the K Q value, indicating that similar domain unzipping has taken place in the failing RyR2 even without addition of DPs. K201 decreased the K Q of the failing RyR2 to a normal level ( Figure 5, g ).
Effect of domain peptides on Ca 21 sparks in normal and failing cardiomyocytes
In order to investigate how the domain-unzipping effect of DP163-195 or DP4090-4123 is reflected upon the cardiomyocyte function, we incorporated DP163-195 or DP4090-4123 into the normal and failing cardiomyocytes by mediation of BioPorter (see Methods). Successful incorporation of DP163-195 or DP4090-4123 into the cell was confirmed by detecting the intra-cellular fluorescence signal of Alexalabelled DPs ( Figure 4A) .
We monitored spontaneous Ca 2þ sparks in cardiomyocytes at two different extracellular [Ca 2þ ]s: 2 and 5 mmol/L. As shown in Figure 4B , the occurrence of Ca 2þ sparks was less frequent in normal cardiomyocytes. However, incorporation of DP163-195 or DP4090-4123 into normal cardiomyocytes resulted in a significant increase in the Ca 2þ spark frequency particularly at [Ca 2þ ]¼5 mmol/L. Failing cardiomyocytes showed high Ca 2þ spark frequency similar to the peptidetreated normal myocytes, even without introduction of the peptides. By incorporation of the peptides, both FWHM and FDHM changed in the same direction as spark frequency, whereas only spark amplitude changed in an opposite direction. This indicates that as Ca 2þ spark frequency increases, Ca 2þ spark amplitude decreases, and a Ca 2þ spark spreads more in time and spatial direction. Incorporation of either DP163-195-mut (ARVC Arg-176-Gln mutation) or DP4090-4123-mut (CPVT Asn-4104-Lys mutation) into normal cardiomycytes produced no appreciable effect on the Ca 2þ spark frequency (data not shown). Protein delivery reagent (Bioporter) alone also had no effect on the Ca 2þ spark frequency (data not shown). In normal cardiomyocytes, K201 inhibited the DP163-195-induced Ca 2þ sparks, but not those induced by DP4090-4123 ( Figure 4C) . Addition of K201 inhibited the Ca 2þ spark in failing cardiomyocytes, even in the presence of DP163-195. However, when DP4090-4123 was Figure 3 Continued incorporated into the failing cardiomyocytes, K201 produced virtually no effect on the Ca 2þ spark frequency. In response to K201, both FWHM and FDHM again changed in the same direction as Ca 2þ spark frequency, whereas only Ca 2þ spark amplitude changed in an opposite direction.
Discussion
We have previously reported that in failing hearts the interdomain interaction between N-terminal (1-600) and central domain (2000-2500) of RyR2 becomes defective, resulting in abnormal intracellular Ca 2þ handling, such as Ca 2þ leak from RyR2 and prolonged Ca 2þ transient. 9 The present study has uncovered several new mechanisms of domain-mediated RyR2 channel regulation and its pathology. Thus, it was found that defective inter-domain interactions not only in the N-terminal domain/central domain but also in IP-domain (putative partner domain of I-domain, which remains to be identified)/I-domain causes various pro-arrhythmia states, such as increased frequency of spontaneous Ca 2þ sparks and appearance of DAD.
There are several reports supporting the view that the I-domain (3722-4610) is involved in the regulation of channel gating. George et al. 11, 20 have shown that functional coupling between the cytoplasmic and transmembrane domains of RyR2 is mediated by the I-domain. Thus, sudden cardiac death (SCD)-linked mutations occurring in the I-domain (N4104K and R4496C) cause RyR2 channel instability via defective inter-domain interaction, resulting in Ca 2þ release dysfunction. Other investigators also empathized the important role of several sub-domains located within the I-domain in the regulation of channel gating. Xiong et al. 21 found that the 4064-4210 residue segment of RyR1 shows a CaM-like sequence (CaMLD), and suggested that this region may be involved in the mechanism of Ca 2þ -dependent channel activation. The fact that CPVT mutations are not randomly scattered over the I-domain, but rather clustered in a rather restricted region; namely in the 3778-4200 region, especially in the 4090-4123 region, suggests that the sub-domain corresponding to DP4090-4123 plays a critical role on normal channel gating. We recently identified the K201-binding site as domain2114-2149 of the ryanodine receptor (RyR2), and the binding of K201 to this domain corrects the defective inter-domain interaction between N-terminal (1-600) and central regions (2000-2500) of RyR2 in pacing-induced failing hearts. 23 The effect of K201 on the mode of interdomain interactions described here has provided a further, new insight into the underlying mechanism for diastolic spontaneous Ca 2þ sparks and DAD seen in failing cardiomyocytes. As shown, the primary action of K201 on the channel function of RyR2 is the correction of unwanted domain unzipping between the N-terminal and central domains seen in failing SR or in DPc10-introduced normal SR. 9 The increase in Ca 2þ spark frequency seen in failing cardiomyocytes was inhibited by K201, but when DP4090-4123 was incorporated into the failing cardiomyocytes, Ca 2þ sparks remained abnormal even in the presence of K201. These findings suggest that in the tachycardia-induced failing hearts Ca 2þ sparks are indeed induced by defective interdomain interaction between N-terminal and central domains. The fact that K201 is less effective in correcting the defective IP-domain/I-domain interaction suggests that K201 may also be less effective in correcting the problem produced by CPVT mutations within the I-domain. The fact that K201 was not effective in the R4496C RyR2 mutant in knock-in mice, which showed bi-directional VT, 10 seems to be consistent with the present data that neither Ca 2þ leak nor Ca 2þ sparks, induced by DP4090-4123, was inhibited by K201. The point mutation, such as R4496C or N4104K at I-domain, seen in CPVT may directly induce domain unzipping between IP-domain and I domain, independent of the mode of inter-domain interaction between N-terminal and central domains.
While elevation of SR Ca 2þ content obviously increases the amount of releasable Ca 2þ , it may become as a causative factor of spontaneous diastolic SR Ca 2þ release. 24 In failing hearts, in which SR Ca 2þ content is decreased, 9 Ca 2þ spark frequency was quite high even in baseline conditions, and increasing [Ca 2þ ] further increased the Ca 2þ spark frequency. This suggests that the threshold of SR Ca 2þ load for the induction of spontaneous Ca 2þ spark is made much lower in failing hearts than in normal hearts. With regard to this, Jiang et al. 25, 26 recently proposed that in mutation-linked RyR2 disorder the threshold of SR Ca 2þ content for spontaneous Ca 2þ release, referred as storeoverload-induced Ca 2þ release (SOICR), was much lower than normal RyR2. The SOICR may also be involved in the defective channel gating in failing hearts, which may also be caused by defective inter-domain interaction in failing RyR2.
Although we have not identified IP-domain yet, the project for identification of IP-domain using LC/MS spectroscopy is now on-going.
In conclusion, three hot regions within RyR2 (N-terminal, central, and I-domains), harbouring many ARVC2 or CPVT mutations, may play a critical role in regulating channel function. Defective inter-domain interactions among these domains may lead to serious problems of channel gating, as seen in abnormal Ca 2þ spark events and DAD, leading to heart failure and lethal arrhythmia. 
